The pharmacogenetics of codeine pain relief in the postpartum period

Pharmacogenomics Journal

Volumn 15, Issue 5, 2015, Pages 430-435

  Baber, M ^a,b   Chaudhry, S ^a   Kelly, L ^a   Ross, C ^c   Carleton, B ^c,d   Berger, H ^e   Koren, G ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; CODEINE; CYTOCHROME P450 2D6; GLUCURONOSYLTRANSFERASE 2B7; MULTIDRUG RESISTANCE PROTEIN 1; GLUCURONOSYLTRANSFERASE; MU OPIATE RECEPTOR; OPRM1 PROTEIN, HUMAN; UGT2B7 PROTEIN, HUMAN;

ABCB1 GENE; ADULT; ARTICLE; ASIAN; CAUCASIAN; CESAREAN SECTION; COMT GENE; CYP2D6 GENE; ETHNIC DIFFERENCE; FEMALE; GENE; HUMAN; MATERNAL AGE; OPRM1 GENE; PHARMACOGENETICS; POSTPARTUM PAIN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; UGT2B7 GENE; VISUAL ANALOG SCALE; ADVERSE EFFECTS; ANALGESIA; GENETICS; GENOTYPE; PAIN; PATHOLOGY; PREGNANCY; PUERPERIUM;

ADULT; CESAREAN SECTION; CODEINE; FEMALE; GENOTYPE; GLUCURONOSYLTRANSFERASE; HUMANS; PAIN; PAIN MANAGEMENT; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTPARTUM PERIOD; PREGNANCY; RECEPTORS, OPIOID, MU;

EID: 84942195216     PISSN: 1470269X     EISSN: 14731150     Source Type: Journal    
DOI: 10.1038/tpj.2015.3     Document Type: Article

References (37)

1. Peter EA, Janssen PA, Grange CS, Douglas MJ. Ibuprofen versus acetaminophen with codeine for the relief of perineal pain after childbirth: a randomized controlled trial. CMAJ 2001; 165: 1203-1209.
2. Lötsch J, Rohrbacher M, Schmidt H, Doehring A, Brockmöller J, Geisslinger G. Can extremely low or high morphine formation from codeine be predicted prior to therapy initiation? Pain 2009; 144: 119-124.
3. Madadi P, Shirazi F, Walter FG, Koren G. Establishing causality of CNS depression in breastfed infants following maternal codeine use. Paediatr Drugs 2008; 10: 399-404.
4. Willmann S, Edginton AN, Coboeken K, Ahr G, Lippert J. Risk to the breast-fed neonate from codeine treatment to the mother: a quantitative mechanistic modeling study. Clin Pharmacol Ther 2009; 86: 634-643.
5. Fagerlund TH, Braaten O. No pain relief from codeine...? An introduction to pharmacogenomics. Acta Anaesthesiol Scand 2001; 45: 140-149.
6. Sindrup SH, Brøsen K. The pharmacogenetics of codeine hypoalgesia. Pharmacogenetics 1995; 5: 335-346.
7. Gasche Y, Daali Y, Fathi M, Chiappe A, Cottini S, Dayer P et al. Codeine intoxication associated with ultrarapid CYP2D6 metabolism. N Engl J Med 2004; 351: 2827-2831.
8. Sia AT, Lim Y, Lim EC, Goh RW, Law HY, Landau R et al. A118G single nucleotide polymorphism of human mu-opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia. Anesthesiology 2008; 109: 520-526.
9. Tan EC, Lim EC, Teo YY, Lim Y, Law HY, Sia AT. Ethnicity and OPRM variant independently predict pain perception and patient-controlled analgesia usage for post-operative pain. Mol Pain 2009; 5: 32.
10. Smith HS. Opioid metabolism. Mayo Clin Proc 2009; 7: 613-624.
11. Sawyer MB, Innocenti F, Das S, Cheng C, Ramírez J, Pantle-Fisher FH et al. A pharmacogenetic study of uridine diphosphate-glucuronosyltransferase 2B7 in patients receiving morphine. Clin Pharmacol Ther 2003; 73: 566-574.
12. Portenoy RK, Thaler HT, Inturrisi CE, Friedlander-Klar H, Foley KM. The metabolite morphine-6-glucuronide contributes to the analgesia produced by morphine infusion in patients with pain and normal renal function. Clin Pharmacol Ther 1992; 51: 422-431.
13. Campa D, Gioia A, Tomei A, Poli P, Barale R. Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief. Clin Pharmacol Ther 2008; 83: 559-566.
14. Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmöller J, Johne A et al. Functional polymorphisms of the human multi-drug resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 2000; 97: 3473-3478.
15. Meineke I, Freudenthaler S, Hofmann U, Schaeffeler E, Mikus G, Schwab M et al. Pharmacokinetic modeling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphine. Br J Clin Pharmacol 2002; 54: 592-603.
16. Lee PJ, Delaney P, Keogh J, Sleeman D, Shorten GD. Catecholamine-omethyltransferase polymorphisms are associated with postoperative pain intensity. Clin J Pain 2011; 27: 93-101.
17. Dai F, Belfer I, Schwartz CE, Banco R, Martha JF, Tighioughart H et al. Association of catechol-O-methyltransferase genetic variants with outcome in patients undergoing surgical treatment for lumbar degenerative disc disease. Spine J 2010; 10: 949-957.
18. Rakvåg TT, Klepstad P, Baar C, Kvam TM, Dale O, Kaasa S et al. The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT ) gene may influence morphine requirements in cancer pain patients. Pain 2005; 116: 73-78.
19. Kelly LE, Chaudhry SA, Rieder MJ, 't Jong G, Moretti ME, Lausman A et al. A clinical tool for reducing central nervous system depression among neonates exposed to codeine through breast milk. PLoS One 2013; 8: e70073.
20. Vandervaart S, Berger H, Tam C, Goh YI, Gijsen VM, de Wildt SN et al. The effect of distant reiki on pain in women after elective Caesarean section: a double-blinded randomized controlled trial. BMJ Open 2011; 1: e000021.
21. VanderVaart S, Berger H, Sistonen J, Madadi P, Matok I, Gijsen VM et al. CYP2D6 polymorphisms and codeine analgesia in postpartum pain management: a pilot study. Ther Drug Monit 2011; 33: 425-432.
22. Bellville JW, Forres WH Jr, Miller E, Brown BW Jr. Influence of age on pain relief from analgesics. A study of postoperative patients. JAMA 1971; 217: 1835-1841.
23. Janicki PK, Schuler G, Francis D, Bohr A, Gordin V, Jarzembowski T et al. A genetic association study of the functional A118G polymorphism of human mu-opioid receptor gene in patients with acute and chronic pain. Anesth Analg 2006; 103: 1011-1017.
24. Coulbault L, Beaussier M, Verstuyft C, Weickmans H, Dubert L, Trégouet D et al. Environmental and genetic factors associated with morphine response in the postoperative period. Clin Pharmacol Ther 2006; 79: 316-324.
25. Mahmoud S, Thorsell A, Sommer WH, Heilig M, Holgate K, Bartlett SE et al. Pharmacological consequence of the A118G ? opioid receptor polymorphism on morphine-and fentanyl-mediated modulation of Ca2+ channels in humanized mouse sensory neurons. Anesthesiology 2011; 115: 1054-1062.
26. Zhang Y, Wang D, Johnson AD, Papp AC, Sadeé W. Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. J Biol Chem 2005; 230: 32618-32624.
27. Holthe M, Rakvåg TN, Klepstad P, Idle JR, Kaasa S, Krokan HE et al. Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients. Pharmacogenomics 2003; 3: 17-26.
28. Lötsch J, Kobal G, Stockmann A, Brune K, Geisslinger G. Lack of analgesic activity of morphine-6-glucuronide after short-term intravenous administration in healthy volunteers. Anesthesiology 1997; 87: 1348-1358.
29. Carnie JC, Perks D. The pattern of postoperative analgesic administration in non-English speaking Asian women following caesarean section. Ann R Coll Surg Engl 1984; 66: 365-366.
30. Houghton IT, Aun CS, Gin T, Lau JT. Inter-ethnic differences in postoperative pethidine requirements. Anaesth Intensive Care 1992; 20: 52-55.
31. Konstantatos AH, Imberger G, Angliss M, Cheng CH, Meng AZ, Chan MT. A prospective cohort study comparing early opioid requirement between Chinese from Hong Kong and Caucasian Australians after major abdominal surgery. Br J Anaesth 2012; 109: 797-803.
32. Sadhasivam S, Chidambaran V. Pharmacogenomics of opioids and perioperative pain management. Pharmacogenomics 2012; 13: 1719-1740.
33. Lampe JW, Bigler J, Bush AC, Potter JD. Prevalence of polymorphisms in the human UDP-glucuronosyltransferase 2B family: UGT2B4(D458E), UGT2B7(H268Y), and UGT2B15(D85Y). Cancer Epidemiol Biomarkers Prev 2000; 9: 329-333.
34. Crews KR, Gaedigk A, Dunnenberger HM, Klein TE, Shen DD, Callaghan JT et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype. Clin Pharmacol Ther 2012; 91: 321-326.
35. Madadi P, Koren G. Pharmacogenomics principles: introduction to personalized medicine. In: Langman LJ, Dasgupta A (eds). Pharmacogenomics in Clinical Therapeutics. John Wiley & Sons Ltd: Chichester, 2012, pp 1-14.
36. Kim K-M, Kim H-K, Lim SH, Cheong SH, Choi E-J, Kang H et al. Effect of genetic polymorphisms of OPRM1, ABCB1, CYP3A4/5 on postoperative fentanyl consumption in Koren gynecological patients. Int J Clin Pharmacol Ther 2013; 51: 383-392.
37. Yang JC, Clark WC, Tsui SL, Ng KF, Bennett CS. Preoperative multidimensional affect and pain survey (MAPS) scores predict postcolectomy analgesia requirement. Clin J Pain 2000; 16: 314-320.